seretide diskus 50100 mcg
glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - fluticasone propionate 100 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.
seretide diskus 50250 mcg
glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - fluticasone propionate 250 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. seretide (50/250 mcg) is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.
seretide diskus 50500 mcg
glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - fluticasone propionate 500 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. seretide (50/500 mcg) is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.
flixotide diskus 100 mcg
glaxo smith kline (israel) ltd - fluticasone propionate - powder for inhalation - fluticasone propionate 100 mcg - fluticasone - prophylactic management of all grades of asthma.
augmentin es powder for oral suspension with strawberry flavour
glaxo wellcome production - amoxicillin (amoxicillin trihydrate), clavulanic acid (potassium clavulanate) - powder for oral suspension with strawberry flavour - 600mg/5ml+ 42.9mg/5ml
seretide evohaler
glaxo wellcome production - salmeterol (salmeterol xinafoate), fluticasone (fluticasone propionate) - aerosol for inhalation - 25mcg/dose+250mcg/dose
seretide accuhaler / diskus 50mcg+100mcg powder for inhalation
glaxo wellcome production - salmeterol (salmeterol xinafoate), fluticasone (fluticasone propionate) - powder for inhalation - 50mcg+100mcg
seretide accuhaler / diskus 50mcg+500mcg powder for inhalation
glaxo wellcome production - salmeterol (salmeterol xinafoate), fluticasone (fluticasone propionate) - powder for inhalation - 50mcg+500mcg
seretide accuhaler / diskus 50mcg+250mcg powder for inhalation
glaxo wellcome production - salmeterol (salmeterol xinafoate), fluticasone (fluticasone propionate) - powder for inhalation - 50mcg+250mcg
seretide diskus 50100 mcg
glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - fluticasone propionate 100 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.